ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 7 of 130 for:    (domestic or partner) AND (violence OR abuse)

Types of Intimate Partner Violence and Women's Health

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03469739
Recruitment Status : Completed
First Posted : March 19, 2018
Last Update Posted : March 19, 2018
Sponsor:
Information provided by (Responsible Party):
University of Bristol

Brief Summary:
This study uses data from 29,990 women from 12 different countries collected by the WHO multi-country study on women's health and domestic violence to capture the effect of different types, frequency and timing of IPV on self-reported health, symptoms and suicidal behaviours.

Condition or disease
Domestic Violence

Detailed Description:

Intimate partner violence (IPV) has detrimental effects on physical and mental health, risks to children and is associated with wider societal and healthcare costs. Previous analysis of the WHO multi-country study on women's health and domestic violence found significant associations between physical and sexual IPV and self-reported ill-health, symptomatology and suicidal behaviours.

Real experience of IPV can comprise different combinations of emotional, physical and sexual abuse, and different timings and frequencies of these. A more nuanced testing of exposure to these different combinations of IPV and associations with health is needed.

This study uses data from 29,990 women from 12 different countries collected by the WHO multi-country study on women's health and domestic violence to capture the effect of different combination types, frequency and timing of IPV on self-reported health, symptoms and suicidal behaviours.


Study Type : Observational
Actual Enrollment : 29990 participants
Observational Model: Other
Time Perspective: Cross-Sectional
Official Title: Types of Intimate Partner Violence and Women's Health: Findings From the WHO Multi-country Study on Women's Health and Intimate Partner Violence
Study Start Date : June 2016
Actual Primary Completion Date : August 2017
Actual Study Completion Date : August 2017

Resource links provided by the National Library of Medicine





Primary Outcome Measures :
  1. Participant description of their current overall state of health [ Time Frame: Preceding 4 weeks ]
    Participant description of their current overall state of health- a choice of options- excellent, good, fair, poor or very poor.


Secondary Outcome Measures :
  1. Participant reported health in the last 4 weeks- problems walking around, doing usual activities, pain or discomfort, problems with memory or concentration, dizziness or vaginal discharge. Measured by questionnaire. [ Time Frame: Preceding 4 weeks ]
    Participant rating of various health aspects in last 4 weeks

  2. Emotional distress. Measured by questionnaire of 20 different symptoms of emotional distress. SRQ-20 (score of 20 different symptoms of emotional distress with yes/no answers) [ Time Frame: Preceding 4 weeks ]
    Self Reporting Questionnaire-20 (SRQ-20)- aggregate score of 20 different symptoms of emotional distress with yes/no answers

  3. Participant reported ever suicidal thoughts or attempts; measured by questionnaire. [ Time Frame: Up to 49 years ]
    Participants reporting ever having suicidal thoughts or ever attempting suicide

  4. Participant reported medication used for sleep/ pain; measured by questionnaire. [ Time Frame: Preceding 4 weeks ]
    Participants reporting medication use



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   15 Years to 49 Years   (Child, Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
This study consists of further analysis of 29,990 interviews conducted with women in 12 different countries coordinated by the World Health Organisation. They report in most sites around 1500 women between 15 and 49 years old were interviewed. Countries included were Bangladesh, Brazil, Cambodia, Ethiopia, Japan, Maldives, Namibia, Peru, Samoa, Serbia and Montenegro, Thailand and the United Republic of Tanzania.
Criteria

Inclusion Criteria:

  • The WHO report that in most sites, a representative sample of women was obtained using a two-stage cluster sampling scheme to select households and then only one woman per household was randomly selected per household for interview.

Exclusion Criteria:


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03469739


Sponsors and Collaborators
University of Bristol
Investigators
Study Director: Gene Feder, MD FRCGP University of Bristol
Principal Investigator: Lucy C Potter, MB ChB University of Bristol